BBR Partners LLC Buys Shares of 6,014 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

BBR Partners LLC bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 6,014 shares of the company’s stock, valued at approximately $564,000.

Several other large investors have also recently bought and sold shares of the stock. Charles Schwab Investment Management Inc. increased its stake in GE HealthCare Technologies by 12.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,710,938 shares of the company’s stock valued at $254,422,000 after buying an additional 290,019 shares during the period. Van ECK Associates Corp acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $208,513,000. FMR LLC grew its stake in shares of GE HealthCare Technologies by 4.1% in the 3rd quarter. FMR LLC now owns 2,165,826 shares of the company’s stock worth $203,263,000 after purchasing an additional 84,411 shares during the last quarter. Swiss National Bank grew its stake in shares of GE HealthCare Technologies by 0.5% in the 3rd quarter. Swiss National Bank now owns 1,287,187 shares of the company’s stock worth $120,802,000 after purchasing an additional 6,500 shares during the last quarter. Finally, The Manufacturers Life Insurance Company grew its stake in shares of GE HealthCare Technologies by 18.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,245,961 shares of the company’s stock worth $97,088,000 after purchasing an additional 189,956 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Activity at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares of the company’s stock, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.27% of the company’s stock.

Wall Street Analyst Weigh In

GEHC has been the topic of several recent research reports. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Wednesday, September 18th. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective on the stock. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their price objective for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. Finally, Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.36.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $83.00 on Thursday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The stock has a market cap of $37.92 billion, a P/E ratio of 22.80, a P/E/G ratio of 2.96 and a beta of 1.24. The firm has a 50 day simple moving average of $88.19 and a 200 day simple moving average of $83.61. GE HealthCare Technologies Inc. has a 52 week low of $66.39 and a 52 week high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter last year, the firm earned $0.99 earnings per share. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.30%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.